Levin Michaela bought ACRV
August 31, 2026 · Form 4 insider transaction
Levin Michaela bought 30,000 shares of Acrivon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderLevin Michaela
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 31, 2026
Filing dateSeptember 2, 2026
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in full on September 1, 2027, subject to the Reporting Person's continuous service through such vesting date.